Background: Acinetobacter baumannii is a gram-negative pathogen that is highly resistant to
antibiotics. This bacterium can cause severe systemic infections, especially in hospitalized …

Imipenem-resistant multi-drug resistant (IR-MDR) Acinetobacter baumannii has been
emerged as a morbidity successful nosocomial pathogen throughout the world. To address …

Acinetobacter baumannii is an opportunistic nosocomial pathogen and one of the six most
important multidrug-resistant microorganisms in intensive care units (ICU). The aim of this …

Background In the last decade, incidences of carbapenem‐resistant Acinetobacter
baumannii have been increasingly reported worldwide. Consequently, A. baumannii was …

Acinetobacter baumannii is a ubiquitous pathogen that has emerged as a major cause of
healthcare-associated infections. Acinetobacter baumannii usually causes respiratory tract …

Background Multidrug resistance in Acinetobacter baumannii is constantly on the rise. There
has also been an increase in the morbidity and mortality of patients with infection by the …

Background: Acinetobacter baumannii is one of the most important pathogen in hospital
acquired infections, especially in intensive care units (ICUs). This opportunistic pathogen …

Objectives Acinetobacter baumannii is a bacterium responsible for health care-associated
infections, and it frequently develops multiple drug resistance (MDR). The prevalence of …

Background: Nosocomial infections due to high mortality and economic cost are one of the
most important challenges that hospitals face with it. Reports show that hospital acquired …

Acinetobacter baumannii is an emerging human pathogen that causes hospital-acquired
infections. The trend in increased antimicrobial resistance limits the choice of effective …